FDA Grants Orphan Drug Designation to Tonix Pharmaceuticals
Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) today announced that the U.S. Food and Drug Administration (FDA) has granted an Orphan-Drug Designation for TNX-2900. Stock Sruged 46% Shares Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) gained over 46% following the announcement. Usage...